A panel of experts reviews the current treatment landscape of atopic dermatitis with a focus on recently approved JAK inhibitors.
EP. 1: Atopic Dermatitis Overview: Pathophysiology, Diagnosis, and Burden
Expert perspectives on the nature of atopic dermatitis, ranging from diagnosis and pathophysiology to the clinical and social burden it places on patients.
EP. 2: Treatment for Mild to Moderate vs Moderate to Severe Atopic Dermatitis
Experts define stages of atopic dermatitis and share insight on the conventional treatment landscape for mild to moderate and moderate to severe atopic dermatitis.
EP. 3: JAK Inhibitors in Atopic Dermatitis: Historical Use and Mechanisms of Action
Focusing on JAK inhibitors, panelists consider the historical use of these agents in atopic dermatitis and their corresponding mechanisms of action.
EP. 4: Topical Ruxolitinib Use in Atopic Dermatitis
A panel of experts review the use of topical ruxolitinib in atopic dermatitis, shedding light on safety and efficacy considerations.
EP. 5: Recent Approval of Oral JAK Inhibitors for Atopic Dermatitis
A brief review of 2 oral JAK inhibitors recently approved for patients with atopic dermatitis.
EP. 6: Atopic Dermatitis: Practical Advice on Selecting and Using JAK Inhibitors
Concluding their focused discussion on JAK inhibitors in atopic dermatitis, panelists share advice on the optimal selection based on route of administration and use of these agents.
EP. 7: Ongoing Challenges in the Management of Atopic Dermatitis
Experts share insight on the challenges inherent in treating patients with atopic dermatitis despite recent advances in therapy.
EP. 8: Key Takeaways on the Management of Atopic Dermatitis
Panelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.
2 Clarke Drive Cranbury, NJ 08512